Evidence map›Paper›PMID 33255985›Full record

ReviewPathogens (Basel, Switzerland)2020

The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections.

Alexey A Lozhkov, Sergey A Klotchenko, Edward S Ramsay, Herman D Moshkoff, Dmitry A Moshkoff, Andrey V Vasin, Maria S Salvato

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Gut microbes · 2026
    Article
  3. Dual Blockade of LILRB1 and LILRB2 Enhances Antiviral Immune Responses in SIV Infection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Interferon-JAK-STAT Axis in Bone Metabolism.Current osteoporosis reports · 2026
    Review
  9. Article
  10. PulmonaromFrontiers in cellular and infection microbiology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Alexey A LozhkovPeter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia.ORCID 0000-0001-5906-7136
Sergey A KlotchenkoSmorodintsev Research Institute of Influenza, Russian Ministry of Health, 196376 St. Petersburg, Russia.ORCID 0000-0003-0289-6560
Edward S RamsaySmorodintsev Research Institute of Influenza, Russian Ministry of Health, 196376 St. Petersburg, Russia.
Herman D MoshkoffRussian Technological University (MIREA), 119454 Moscow, Russia.
Dmitry A MoshkoffPeter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia.
Andrey V VasinPeter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia.
Maria S SalvatoGlobal Virus Network(GVN), 725 W Lombard St, Baltimore, MD 21201, USA.ORCID 0000-0002-3357-5391
Peter the Great St. Petersburg Polytechnic University · RUMinistry of Health of the Russian Federation · RUMIREA - Russian Technological University · RUUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferons (IFN) are crucial for the innate immune response. Slightly more than two decades ago, a new type of IFN was discovered: the lambda IFN (type III IFN). Like other IFN, the type III IFN display antiviral activity against a wide variety of infections, they induce expression of antiviral, interferon-stimulated genes (

Indexed as

influenzainnate immunityinterferon stimulated genesinterferons-α/βinterferons-λrespiratory viruses

Identifiers

PMID33255985
PMCPMC7760417
OpenAlexW3107546937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.